ScholarIQanswers from OpenAlex & ORCID
Žhong Yuan
ResearcherPublications, citations & collaboration network
Žhong Yuan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Žhong Yuan have?
ScholarIQindexed works
Žhong Yuan has 140 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Žhong Yuan have?
ScholarIQcitation count
Žhong Yuan has 4,345 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Žhong Yuan?
ScholarIQh-index
Žhong Yuan has an h-index of 33 in OpenAlex.
What is the i10-index of Žhong Yuan?
ScholarIQi10-index
Žhong Yuan has an i10-index of 69 in OpenAlex.
What is the ORCID of Žhong Yuan?
ScholarIQorcid
The ORCID for Žhong Yuan is on the source record.
What is the OpenAlex record for Žhong Yuan?
ScholarIQopenalex
The OpenAlex for Žhong Yuan is on the source record.
What are the most-cited papers on Žhong Yuan?
ScholarIQmost cited works
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
Scott M. Grundy, Gloria Lena Vega, Žhong Yuan, Wendy P. Battisti, William E. Brady, Joanne Palmisano
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
Milan Radovich, Guanglong Jiang, Bradley A. Hancock, Christopher R. Chitambar, Rita Nanda, Carla I. Falkson, Filipa Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A. Thompson, Robert Graham, Maureen E. Cooper, Dean C. Pavlick, Lee A. Albacker, Jeffrey P. Gregg, Jeffrey P. Solzak, Yu-Hsiang Chen, Casey Bales, Erica Cantor, Fei Shen, Anna Maria Storniolo, Sunil Badve, Tarah J. Ballinger, Chun-Li Chang, Žhong Yuan, Cagri A. Savran, Kathy D. Miller, Bryan P. Schneider
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
Christie M. Ballantyne, Nicola Abate, Žhong Yuan, Thomas King, Joanne Palmisano
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
Jacob A. Udell, Žhong Yuan, Toni Rush, Nicholas Sicignano, Michael S. Galitz, Norman Rosenthal
Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors
Christopher L. Taylor, Žhong Yuan, Warren R. Selman, Robert A. Ratcheson, Alfred A. Rimm